Furthermore, the role of peripheral blood as a diagnostic and monitoring tool, including the assessment of cell-free circulating tumor DNA, circulating plasma cells (CPCs), and M-proteins, warrants investigation, particularly given the limitations of bone marrow biopsies. Here, MYOM2 is linked to neoplasm.